Axim Biotechnologies Inc (AXIM)

[TexasMarvL]

Bottom line Quote from Page 42 of 10-Q

Market demand for the system is expected to be moderate to begin with until we become a preferred vendor with a large purchasing group or until we are granted a waiver from CLIA.



At that time we expect high demand for our system. We also expect high demand for our recently developed MMP-9 quantitative test once we get FDA 510k clearance.